comparemela.com

Latest Breaking News On - Merlin capital - Page 15 : comparemela.com

Barclays Lowers Burlington Stores (NYSE:BURL) Price Target to $227 00

Burlington Stores (NYSE:BURL – Get Rating) had its price objective decreased by Barclays from $237.00 to $227.00 in a report issued on Friday, The Fly reports. BURL has been the subject of a number of other reports. Sanford C. Bernstein assumed coverage on shares of Burlington Stores in a research note on Monday, March 14th. […]

Marc Benioff Sells 2,300 Shares of salesforce com, inc (NYSE:CRM) Stock

salesforce.com, inc. (NYSE:CRM – Get Rating) CEO Marc Benioff sold 2,300 shares of the stock in a transaction on Wednesday, March 30th. The stock was sold at an average price of $216.02, for a total value of $496,846.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. […]

Zacks: Brokerages Anticipate onsemi (NASDAQ:ON) Will Post Quarterly Sales of $1 90 Billion

Wall Street brokerages expect onsemi (NASDAQ:ON – Get Rating) to post $1.90 billion in sales for the current fiscal quarter, Zacks reports. Nine analysts have made estimates for onsemi’s earnings, with estimates ranging from $1.90 billion to $1.91 billion. onsemi reported sales of $1.48 billion in the same quarter last year, which indicates a positive […]

NeoPhotonics Co (NYSE:NPTN) Receives Consensus Recommendation of Hold from Brokerages

Shares of NeoPhotonics Co. (NYSE:NPTN – Get Rating) have earned an average rating of “Hold” from the eleven research firms that are presently covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1-year target price […]

Zacks: Brokerages Expect Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Will Announce Quarterly Sales of $2 08 Billion

Brokerages expect that Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) will post $2.08 billion in sales for the current quarter, according to Zacks. Eight analysts have provided estimates for Vertex Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $1.94 billion and the highest estimate coming in at $2.15 billion. Vertex Pharmaceuticals posted sales […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.